
VoxelCloud provides automated medical image analysis services and diagnosis assistance based on AI and cloud computing technologies. The company provides to clinical practices and practitioners automated medical image analytics and diagnostics services based on artificial intelligence and cloud computing technologies. VoxelCloud's proprietary algorithms offer accurate, accessible, and personalized medical image analysis through deep learning and related AI techniques. The company's current products cover lung cancer, retinal diseases, and coronary heart disease. VoxelCloud also has offices in Shanghai and Suzhou in China, as well as a satellite R&D team in Phoenix. The company was founded in Los Angeles in 2016.

VoxelCloud provides automated medical image analysis services and diagnosis assistance based on AI and cloud computing technologies. The company provides to clinical practices and practitioners automated medical image analytics and diagnostics services based on artificial intelligence and cloud computing technologies. VoxelCloud's proprietary algorithms offer accurate, accessible, and personalized medical image analysis through deep learning and related AI techniques. The company's current products cover lung cancer, retinal diseases, and coronary heart disease. VoxelCloud also has offices in Shanghai and Suzhou in China, as well as a satellite R&D team in Phoenix. The company was founded in Los Angeles in 2016.
Founded: 2016
Headquarters: Shanghai and Los Angeles
Product focus: AI-powered medical image analysis (radiology, ophthalmology, dermatology)
Regulatory / scale: Some products claimed NMPA Class III certification; 300+ institutional deployments; ~200,000 daily platform uses
Funding stage: Series B (latest reported: 2019-12-07)
Notable investors: Includes Tencent and Sequoia Capital; recent investors include Hermitage Capital and Shenzhen Hongtai Capital Management Group
Automated medical image analysis and clinical decision support for healthcare providers.
2016
Medical imaging / Healthtech
“Backed by a mix of strategic and institutional investors; investor list includes Tencent and Sequoia Capital (earlier rounds) and more recent investors such as Hermitage Capital and Shenzhen Hongtai Capital Management Group.”